Small intestinal bacterial overgrowth (SIBO) has been linked to common gastrointestinal symptoms; yet its precise definition remains elusive. A new study shows that, when it comes to symptom prediction in functional gastrointestinal disorders, high-throughput sequencing analysis of the microbiome and not jejunal aspiration and culture is the clear winner.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Quigley, E. M. M. The spectrum of small intestinal bacterial overgrowth (SIBO). Curr. Gastroenterol. Rep. 21, 3 (2019).
Pimentel, M., Chow, E. J. & Lin, H. C. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am. J. Gastroenterol. 95, 3503–3506 (2000).
Ford, A. C. et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 7, 1279–1286 (2009).
Sundin, O. H. et al. Does a glucose-based hydrogen and methane breath test detect bacterial overgrowth in the jejunum? Neurogastroenterol. Motil. 30, e13350 (2018).
Berean, K. J. et al. The safety and sensitivity of a telemetric capsule to monitor gastrointestinal hydrogen production in vivo in healthy subjects: a pilot trial comparison to concurrent breath analysis. Aliment. Pharmacol. Ther. 48, 646–654 (2018).
Di Stefano, M. & Quigley, E. M. M. The diagnosis of small intestinal bacterial overgrowth: two steps forward, one step backwards? Neurogastroenterol. Motil. 30, e13494 (2018).
Saffouri, G. B. et al. Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders. Nat. Commun. 10, 2012 (2019).
Mitchell, H. et al. Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research. Aliment. Pharmacol. Ther. 49, 124–139 (2019).
Pittayanon, R. et al. Gut microbiota in patients with irritable bowel syndrome — a systematic review. Gastroenterology https://doi.org/10.1053/j.gastro.2019.03.049 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Quigley, E.M.M. Symptoms and the small intestinal microbiome — the unknown explored. Nat Rev Gastroenterol Hepatol 16, 457–458 (2019). https://doi.org/10.1038/s41575-019-0171-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-019-0171-5
This article is cited by
-
Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm
Indian Journal of Gastroenterology (2020)